Intelligent Bio Solutions (INBS) Cash from Financing Activities (2020 - 2025)
Intelligent Bio Solutions' quarterly Cash from Financing Activities came in at $3.3 million in Q1 2025, down 69.16% year-on-year from $10.8 million in Q1 2024, and up 425.78% quarter-over-quarter from $631744.0 in Q4 2024.
Intelligent Bio Solutions has reported Cash from Financing Activities for 5 years, with the latest figure at $3.3 million in Q1 2025.
- For the quarter ending Q1 2025, Cash from Financing Activities fell 69.16% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2025 stood at $14.8 million (up 17.81% YoY), and the FY2023 full-year result was $1.4 million, changed N/A from the prior year.
- Cash from Financing Activities for Q1 2025 stood at $3.3 million, up from $631744.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $10.8 million in Q1 2024, with the low at $42450.0 in Q3 2024.
- Average Cash from Financing Activities over 4 years is $2.4 million, with a median of $631744.0 recorded in 2024.
- Year-over-year, Cash from Financing Activities surged 526.97% in 2024 and tumbled 69.16% in 2025.
- Tracing INBS's Cash from Financing Activities over 4 years: stood at $498100.0 in 2021, then tumbled by 90.74% to $46110.0 in 2023, then soared by 1270.08% to $631744.0 in 2024, then soared by 425.78% to $3.3 million in 2025.
- The last three Cash from Financing Activities figures came in at $3.3 million (Q1 2025), $631744.0 (Q4 2024), and $42450.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 631,744.00 |
| Dec 31, 2024 | 631,744.00 |
| Sep 30, 2024 | 42,450.00 |
| Sep 30, 2024 | 42,450.00 |
| Mar 31, 2024 | 10.77 Mn |
| Mar 31, 2024 | 10.77 Mn |
| Jun 30, 2023 | 46,110.00 |
| Jun 30, 2023 | 46,110.00 |
| Mar 31, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Mar 31, 2021 | 498,100.00 |
| Mar 31, 2021 | 498,100.00 |
| Dec 31, 2020 | 19.61 Mn |
| Dec 31, 2020 | 19.61 Mn |
| Sep 30, 2020 | 3.29 Mn |
| Sep 30, 2020 | 3.29 Mn |
| Jun 30, 2020 | 201,514.00 |
| Jun 30, 2020 | 201,514.00 |